X

BRKR

Bruker Corp (BRKR) Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR

Bruker Corp (NASDAQ: BRKR) FY 2026 Other Release

Bruker Corp (BRKR) Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications

Bruker Corp (NASDAQ: BRKR) FY 2026 Other Release

Bruker Corp (BRKR) Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum

Bruker Corp (NASDAQ: BRKR) FY 2026 Other Release

Bruker Corp (BRKR) Sec Form 8K

Bruker Corp (NASDAQ: BRKR) Sec Form 8K

Bruker Corp (BRKR) Sec Form 8K

Bruker Corp (NASDAQ: BRKR) Sec Form 8K

Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook

Shares of Bruker Corporation (Nasdaq: BRKR) were down sharply in early trade on Friday, retreating around 10% to 14% after…

Bruker Corp (BRKR) Q4 2025 Earnings Call

Bruker Corp (NASDAQ: BRKR) Q4 2025 Earnings Conference

Bruker Corp (BRKR) Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration

Bruker Corp (NASDAQ: BRKR) FY 2026 Other Release

Bruker Corp (BRKR) Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

Bruker Corp (NASDAQ: BRKR) FY 2026 Product Release

Bruker Corp (BRKR) Q2 2025 Earnings Call Transcript

Bruker Corp (NASDAQ: BRKR) Q2 2025 Earnings Call dated Aug. 04, 2025 Corporate Participants: Joe Kostka — Director, Investor Relations…